STABLECAMP Platform Trial
Non-healing Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs)
Key Facts
About Stability Biologics
Stability Biologics is a private, commercial-stage company operating in the regenerative medicine and advanced wound care sector. Its core business involves the development, manufacturing, and commercialization of a range of human tissue-based products, primarily derived from amniotic and other placental tissues, categorized as cellular, acellular, and matrix-like products (CAMPs). The company is actively generating evidence through a pivotal adaptive platform trial, STABLECAMP, focusing on hard-to-heal diabetic foot ulcers and venous leg ulcers, while also commercializing its products for various surgical and wound indications. With a focus on safety, science, and service, Stability Biologics aims to establish itself as a key provider of biologic solutions in a large and growing market.
View full company profile